Mmetụta mmetụta: 96.97% (95% CI: 83.35% ~ 99.99%)
Nkọwapụta: 100.00% (95% CI: 97.29% ~ 100.00%)
Nke ziri ezi: 99.50% (95% CI: 96.94% ~ 99.99%)
Nsonaazụ ngwa ngwa na nkeji 15-30 ngwa ngwa antigen ngwa ngwa AMRDT120
Nnwale ngwa ngwa maka nchọpụta qualitative nke neutralizing
ọgwụ mgbochi SARS-CoV-2 ma ọ bụ ọgwụ mgbochi ya na ọbara dum, serum, ma ọ bụ plasma.
Nkọwa ngwugwu: 40T/kit, 20T/kit, 10T/kit, 1T/kit.
Mmetụta mmetụta: 96.97% (95% CI: 83.35% ~ 99.99%)
Nkọwapụta: 100.00% (95% CI: 97.29% ~ 100.00%)
Nke ziri ezi: 99.50% (95% CI: 96.94% ~ 99.99%)
Akpa foil, ya na cassstes ule na ndị na-esi nri *20
Ihe nchekwa nyocha * 20 vials;
Ndị na-atụfu ihe atụfu * 20;
Lancet *20
Lodine swab * 20
Ntuziaka maka ojiji*1
Nsonaazụ ọsọ ọsọ na nkeji 15-30 ngwa ngwa antigen ngwa ngwa AMRDT120 eburu n'obi iji
SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) bụ ngwa ngwa immunoassay chromatographic maka nchọpụta qualitative nke na-ewepụ ọgwụ mgbochi SARS-CoV-2 n'ọbara dum, serum, ma ọ bụ plasma.
Nsonaazụ ngwa ngwa na nkeji 15-30 ngwa ngwa antigen ngwa ngwa AMRDT120 PRINCIPLE
SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) bụ maka nchọpụta ọgwụ mgbochi SARS-CoV-2 ma ọ bụ ọgwụ mgbochi ya.A na-ekpuchi sel elu sel angiotensin converting enzyme-2 (ACE2) na mpaghara ahịrị ule yana ngalaba nnabata nnabata (RBD) jikọtara ya na ihe na-egosi.
N'oge nnwale, ọ bụrụ na enwere ọgwụ mgbochi SARS-CoV-2 na-egbochi nje na ụdị ahụ, ọ ga-emeghachi omume na protein RBD-particle conjugate ma ghara imeghachi omume na protein mkpuchi ACE2.Ngwakọta a na-akwaga n'elu akpụkpọ ahụ chromatographically site na capillary omume ma ọ gaghị ejide ya site na antigen ekpuchiri mbụ.Nnwale ngwa ngwa nke SARS-CoV-2 Neutralizing Antibody (COVID-19 Ab) nwere ihe mkpuchi protein RBD.A na-ekpuchi protein ACE2 na mpaghara ahịrị ule.
